Press Releases

A study led by the University at Buffalo (UB) and Roswell Park Cancer Institute (RPCI) has identified beliefs and personality traits that are associated with higher levels of distress in newly diagnosed prostate cancer patients.

More than 150 news organizations from around the country have published stories about the award-winning research conducted by Roswell Park scientists and recently presented at the annual meeting of the American Society of Clinical Oncology.

Many teens with cancer are unable to attend their high school’s prom because of their diagnosis.

A large cooperative-group study directed by the Alliance for Clinical Trials in Oncology has confirmed previous evidence that the drug lenalidomide delays time to disease progression for patients with multiple myeloma and is an important treatment option for patients with this rare but increasingly common cancer of the blood and marrow.

While squamous cell anal carcinomas are rare, representing only about 2% of digestive-system cancer diagnoses, these cancers, which are associated with the human papillomavirus (HPV), sometimes prove very difficult to treat, recurring or developing metastases following standard treatment.

The American Surgical Association (ASA), the nation’s oldest and most prestigious academic society for surgeons recently elected Roswell Park’s Steven Hochwald, MD, FACS, Chief of Gastrointestinal Surgery, as a new Fellow.

Roswell Park Cancer Institute researchers have developed an accurate, individualized post-operative survival calculator and integrated the technology into a mobile application compatible with smartphone technology for oncologists and patients diagnosed with colon cancer.

More than two dozen clinical researchers from Roswell Park Cancer Institute will be among the more than 30,000 cancer specialists gathered in Chicago for the American Society of Clinical Oncology 51st Annual Meeting. Several teams will be presenting the findings of Roswell Park-led research to their colleagues from around the world.

The incidence of melanoma, a deadly form of skin cancer, has increased by more than 250% among children, adolescents and young adults since 1973, according to award-winning research to be presented by Roswell Park Cancer Institute at the American Society of Clinical Oncology 51st Annual Meeting in Chicago.